Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2 competing products in clinical development for Locally Advanced or Metastatic Non-Small Cell Lung Cancer.
Pipeline by Phase
Phase 11
Phase 31
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Trastuzumab Deruxtecan + Cisplatin + Carboplatin + Pembrolizumab + Pemetrexed | Daiichi Sankyo | Phase 3 | Active | 44 |
| T-DXd + Durvalumab + Cisplatin + Carboplatin + Pemetrexed + Volrustomig + Rilvegostomig | Daiichi Sankyo | Phase 1 | Recruiting | 36 |